XML 119 R96.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Other Financial Assets - Summary of Changes in Other Financial Assets (Details) $ in Thousands | 12 Months Ended
--- | ---
Mar. 31, 2018 CAD ($)
Disclosure Of Financial Assets [Line Items] |
Beginning balance | $ 24,030
Additions | 22,439
Fair Value Through Other Comprehensive Income | 38,673
Fair Value Through Profit or Loss | 78,172
Interest revenue | 149
Ending balance | $ 163,463
TerrAscend Corp | Warrants |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTPL
Additions | $ 7,540
Fair Value Through Profit or Loss | 67,614
Ending balance | $ 75,154
AusCann Group Holdings Ltd. | Shares |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVOCI
Beginning balance | $ 18,328
Additions | 1,214
Fair Value Through Other Comprehensive Income | 19,544
Ending balance | $ 39,086
AusCann Group Holdings Ltd. | Options |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTPL
Beginning balance | $ 5,702
Fair Value Through Profit or Loss | 4,785
Ending balance | $ 10,487
James E. Wagner Cultivation Ltd. | Warrants |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTPL
Additions | $ 112
Fair Value Through Profit or Loss | 702
Ending balance | $ 814
James E. Wagner Cultivation Ltd. | Shares |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTOCI
Additions | $ 3,863
Fair Value Through Other Comprehensive Income | 6,728
Ending balance | $ 10,591
James E. Wagner Cultivation Ltd. | Royalty Interest |
Disclosure Of Financial Assets [Line Items] |
Accounting method | amortized cost
Additions | $ 2,500
Interest revenue | 162
Ending balance | $ 2,662
Agripharm Corp. | Warrants |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTPL
Additions | $ 586
Fair Value Through Profit or Loss | (139)
Ending balance | $ 447
Agripharm Corp. | Royalty Interest |
Disclosure Of Financial Assets [Line Items] |
Accounting method | amortized cost
Additions | $ 2,414
Interest revenue | (88)
Ending balance | $ 2,326
Vapium Incorporated | Shares |
Disclosure Of Financial Assets [Line Items] |
Accounting method | cost
Additions | $ 1,210
Ending balance | $ 1,210
Radicle Medical Marijuana Inc | Repayable Debenture |
Disclosure Of Financial Assets [Line Items] |
Accounting method | amortized cost
Additions | $ 3,000
Interest revenue | 75
Ending balance | $ 3,075
HydRx Farms Ltd. | Warrants |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTPL
Fair Value Through Profit or Loss | $ 5,210
Ending balance | $ 5,210
HydRx Farms Ltd. | Shares |
Disclosure Of Financial Assets [Line Items] |
Accounting method | FVTOCI
Fair Value Through Other Comprehensive Income | $ 12,401
Ending balance | $ 12,401

X
- Definition Accounting method used to calculate changes in other financial assets. + References No definition available. + Details
Name: | cgc_AccountingMethodUsedToCalculateChangesInOtherFinancialAssets
Namespace Prefix: | cgc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Additions to investments in other financial assets. + References No definition available. + Details
Name: | cgc_AdditionsToInvestmentsInOtherFinancialAssets
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialAssetsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2017-01-01 -Paragraph 20 -Subparagraph a -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=7&date=2017-03-01&anchor=para_20_a_i&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The gains (losses) recognised in other comprehensive income on financial assets measured at fair value through other comprehensive income, before tax. [Refer: Financial assets measured at fair value through other comprehensive income; Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2018-01-01 -Name IFRS -Number 7 -IssueDate 2017-01-01 -Paragraph 20 -Subparagraph a -Clause viii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=7&date=2017-03-01&anchor=para_20_a_viii&doctype=Standard -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2018-01-01 -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 91 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_91_b&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_GainsLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeBeforeTax
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of revenue arising from interest for financial assets that are measured at amortised cost. [Refer: Interest income; Financial assets at amortised cost] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2018-01-01 -Name IFRS -Number 7 -IssueDate 2017-01-01 -Paragraph 20 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=7&date=2017-03-01&anchor=para_20_b&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_InterestIncomeForFinancialAssetsMeasuredAtAmortisedCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 54 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_54_d&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_OtherNoncurrentFinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_TerrAscendCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=cgc_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_AusCannGroupHoldingsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=cgc_SharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=cgc_OptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_JamesEWagnerCultivationLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=cgc_RoyaltyInterestMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_AgripharmCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_VapiumIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_RadicleMedicalMarijuanaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=cgc_RepayableDebentureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=cgc_HydRxFarmsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |